Results 21 to 30 of about 5,657,584 (240)

Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors [PDF]

open access: yesScientific Reports, 2017
Developing therapeutics that target multiple receptor signaling pathways in tumors is critical as therapies targeting single specific biomarker/pathway have shown limited efficacy in patients with cancer.
Yanni Zhu   +7 more
doaj   +2 more sources

TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content

open access: yesFrontiers in Immunology, 2023
BackgroundTNF-related apoptosis-inducing ligand (TRAIL) is a member of the TNF superfamily that can either induce cell death or activate survival pathways after binding to death receptors (DRs) DR4 or DR5.
Sinem Gunalp   +15 more
doaj   +1 more source

Recent Advances in the Development of Nanodelivery Systems Targeting the TRAIL Death Receptor Pathway

open access: yesPharmaceutics, 2023
The TRAIL (TNF-related apoptosis-inducing ligand) apoptotic pathway is extensively exploited in the development of targeted antitumor therapy due to TRAIL specificity towards its cognate receptors, namely death receptors DR4 and DR5.
Anne V. Yagolovich   +2 more
doaj   +1 more source

TRAIL and its receptors in cardiac diseases

open access: yesFrontiers in Physiology, 2023
Cardiovascular disease is a leading cause of death worldwide. Loss of cardiomyocytes that occurs during many types of damage to the heart such as ischemic injury and stress caused by pressure overload, diminishes cardiac function due to their limited ...
Laurel A. Grisanti
doaj   +1 more source

Genistein Sensitizes Human Cholangiocarcinoma Cell Lines to Be Susceptible to Natural Killer Cells

open access: yesBiology, 2022
Cholangiocarcinoma (CCA) is a lethal bile duct cancer, which has poor treatment outcomes due to its high resistance to chemotherapy and cancer recurrence.
Chutipa Chiawpanit   +4 more
doaj   +1 more source

All About (NK Cell-Mediated) Death in Two Acts and an Unexpected Encore: Initiation, Execution and Activation of Adaptive Immunity

open access: yesFrontiers in Immunology, 2022
NK cells are key mediators of immune cell-mediated cytotoxicity toward infected and transformed cells, being one of the main executors of cell death in the immune system.
Ariel Ramírez-Labrada   +24 more
doaj   +1 more source

Volatile oil of Teucrium alopecurus sensitizes colon cancer cells to TRAIL-induced cell death

open access: yesFrontiers in Bioscience-Scholar, 2021
TNF-related apoptosis-inducing ligand (TRAIL/Apo2L), a member of cytokine family, is known to selectively induce apoptosis in cancer cells. However, developing resistance to TRAIL is a major obstacle in cancer therapy.
Fatma Guesmi   +7 more
doaj   +1 more source

Oxaliplatin resistance in colorectal cancer enhances TRAIL sensitivity via death receptor 4 upregulation and lipid raft localization

open access: yeseLife, 2021
Colorectal cancer (CRC) remains a leading cause of cancer death, and its mortality is associated with metastasis and chemoresistance. We demonstrate that oxaliplatin-resistant CRC cells are sensitized to TRAIL-mediated apoptosis.
Joshua D Greenlee   +6 more
doaj   +1 more source

TRAF2 Controls Death Receptor-Induced Caspase-8 Processing and Facilitates Proinflammatory Signaling

open access: yesFrontiers in Immunology, 2019
Tumor necrosis factor (TNF) receptor associated factor-2 (TRAF2) knockout (KO) cells were generated to investigate the role of TRAF2 in signaling by TNFR1 and the CD95-type death receptors (DRs) TRAILR1/2 and CD95.
Jennifer Kreckel   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy